Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment

Journal of Neurosurgery

Volumn 115, Issue 2, 2011, Pages 281-288

  Etminan, Nima ^a   Peters, Corinn A ^a   Ficnar, Julian ^a   Anlasik, Suzan ^a   Bünemann, Erich ^a   Slotty, Philipp J ^a   Hänggi, Daniel ^a   Steiger, Hans Jakob ^a   Sorg, Rüdiger V ^a   Stummer, Walter ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aminolevulinic acid; Glioma; Invasion; Migration; Oncology; Photodynamic therapy

Indexed keywords

ACTIN; AMINOLEVULINIC ACID; MATRILYSIN; NEUTROPHIL COLLAGENASE;

APOPTOSIS; ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELL VIABILITY; CYTOSKELETON; DOSE RESPONSE; DOWN REGULATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; METASTASIS; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SPHEROID;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; GLIOMA; HUMANS; PHOTOCHEMOTHERAPY; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 79961113470     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.3.JNS10434     Document Type: Article

References (31)

1. Au CM, Luk SK, Jackson CJ, Ng HK, Yow CM, To SS: Differential effects of photofrin, 5-aminolevulinic acid and calphostin C on glioma cells. J Photochem Photobiol B 85:92-101, 2006 (Pubitemid 44566023)
2. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, et al: Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 39:386-393, 2007 (Pubitemid 47041087)
3. Binder DK, Berger MS: Proteases and the biology of glioma invasion. J Neurooncol 56:149-158, 2002 (Pubitemid 34272306)
4. Casas A, Di Venosa G, Vanzulli S, Perotti C, Mamome L, Rodriguez L, et al: Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy. Cancer Lett 271:342-351, 2008
5. Casas A, Sanz-Rodriguez F, Di Venosa G, Rodriguez L, Mamone L, Blázquez A, et al: Disorganisation of cytoskeleton in cells resistant to photodynamic treatment with decreased metastatic phenotype. Cancer Lett 270:56-65, 2008
6. Castano AP, Mroz P, Hamblin MR: Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:535-545, 2006 (Pubitemid 43980542)
7. Chu ES, Wong TK, Yow CM: Photodynamic effect in medulloblastoma: downregulation of matrix metalloproteinases and human telomerase reverse transcriptase expressions. Photochem Photobiol Sci 7:76-83, 2008
8. Dolmans DE, Fukumura D, Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer 3:380-387, 2003 (Pubitemid 37328858)
9. Eljamel MS, Goodman C, Moseley H: ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci 23:361-367, 2008
10. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL: Epidemiology of brain tumors. Neurol Clin 25:867-890, vii, 2007
11. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, et al: Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733-4740, 2009
12. Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, et al: Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27:2897-2909, 2008 (Pubitemid 351620450)
13. Hagemann C, Anacker J, Haas S, Riesner D, Schömig B, Ernestus RI, et al: Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures. BMC Res Notes 3:293, 2010
14. Hirschberg H, Sun CH, Krasieva T, Madsen SJ: Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells. Lasers Surg Med 38:939-945, 2006 (Pubitemid 46037475)
15. Jiang F, Chopp M, Katakowski M, Cho KK, Yang X, Hochbaum N, et al: Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells. Lasers Med Sci 17:280-288, 2002 (Pubitemid 35252885)
16. Juzeniene A, Peng Q, Moan J: Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochem Photobiol Sci 6:1234-1245, 2007 (Pubitemid 350191101)
17. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403, 2006 (Pubitemid 43668737)
18. Madsen SJ, Sun CH, Tromberg BJ, Hirschberg H: Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. J Neurooncol 62:243-250, 2003 (Pubitemid 36591959)
19. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W: Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg 97:970-976, 2002 (Pubitemid 35222423)
20. Rainov NG: A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11:2389-2401, 2000
21. Rainov NG, Söling A: Clinical studies with targeted toxins in malignant glioma. Rev Recent Clin Trials 1:119-131, 2006
22. Rath P, Shi H, Maruniak JA, Litofsky NS, Maria BL, Kirk MD: Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas. Curr Stem Cell Res Ther 4:44-49, 2009
23. Stummer W, Beck T, Beyer W, Mehrkens JH, Obermeier A, Etminan N, et al: Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. J Neurooncol 87:103-109, 2008
24. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
25. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466, 2009
26. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
27. Sutherland RM: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177-184, 1988
28. Tate MC, Aghi MK: Biology of angiogenesis and invasion in glioma. Neurotherapeutics 6:447-457, 2009
29. Tsai T, Ji HT, Chiang PC, Chou RH, Chang WS, Chen CT: ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells. Lasers Surg Med 41:305-315, 2009
30. Uzdensky A, Kolpakova E, Juzeniene A, Juzenas P, Moan J: The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells. Biochim Biophys Acta 1722:43-50, 2005 (Pubitemid 40222404)
31. Yilmaz M, Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:15-33, 2009